CLINICAL_TRIALS
trial_result
· 2020-03-13
Clinical Trial Update: "Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"
Summary
A retrospective study analyzed clinical factors associated with a high benefit of axitinib in metastatic renal cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell | Status: COMPLETED | Results posted: 2020-03-13